Elbit gets FDA approval for ultrasound system:
This article was originally published in Clinica
Elbit Ultrasound has received US marketing approval for its general purpose colour ultrasound system, Synergy. The PC-based system supports digital archiving and communications networks. Elbit, which is based in Haifa, Israel, has completed its acquisition of Elscint's ultrasound business and renamed it Diasonics Israel. Elbit believes a 2D spectral Doppler technique developed by Diasonics could have applications in the diagnosis of placental disorders.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.